Disease-modifying effects of cannabidiol, β-caryophyllene and their combination in Syn1-Cre/Scn1aWT/A1783V mice, a preclinical model of Dravet syndrome

  1. Alonso, C.
  2. Satta, V.
  3. Hernández-Fisac, I.
  4. Fernández-Ruiz, J.
  5. Sagredo, O.
Journal:
Neuropharmacology

ISSN: 1873-7064,  0028-3908

Year of publication: 2023

Volume: 237

Type: Article

DOI: 10.1016/J.NEUROPHARM.2023.109602 GOOGLE SCHOLAR lock_openOpen access editor HANDLE: https://hdl.handle.net/20.500.14352/103445
Docta Complutense: lock_openOpen access Handle

Sustainable development goals

Data source: Scopus